Adjuvant Anti-PD-1 Immunotherapy versus Conventional Therapy for Stage III Melanoma: A Real-World Retrospective Cohort Study

The use of adjuvant therapy has provided survival benefits in patients with advanced melanoma. This study aimed to explore the recurrence and prognosis of the PD-1 inhibitor, conventional interferon (IFN), or observation (OBS) on resected stage III acral and cutaneous melanoma patients through a ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tong, Xu, Yu, Sun, Wei, Yan, Wangjun, Wang, Chunmeng, Hu, Tu, Zhang, Xiaowei, Luo, Zhiguo, Liu, Xin, Chen, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867270/
https://www.ncbi.nlm.nih.gov/pubmed/36678538
http://dx.doi.org/10.3390/ph16010041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867270/
https://www.ncbi.nlm.nih.gov/pubmed/36678538
http://dx.doi.org/10.3390/ph16010041

Ejemplares similares